Cargando…

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction

Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium en...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Woerden, Gijs, van Veldhuisen, Dirk J., Gorter, Thomas M., Willems, Tineke P., van Empel, Vanessa P. M., Peters, Aniek, Pundziute, Gabija, op den Akker, Jeroen W., Rienstra, Michiel, Westenbrink, B. Daan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794962/ https://www.ncbi.nlm.nih.gov/pubmed/34292389 http://dx.doi.org/10.1007/s00380-021-01910-2

Ejemplares similares

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

The value of echocardiographic measurement of epicardial adipose tissue in heart failure patients
por: van Woerden, Gijs, et al.
Publicado: (2022)

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study
por: van Veldhuisen, Dirk J., et al.
Publicado: (2020)

Incident heart failure risk after bariatric surgery: the role of epicardial fat
por: van Woerden, Gijs, et al.
Publicado: (2020)

Obesity, epicardial adipose tissue and left atrial cardiomyopathy in patients with heart failure with preserved ejection fraction: a cardiac MRI based study
por: Lobeek, M, et al.
Publicado: (2023)

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
por: van Veldhuisen, Sophie L, et al.
Publicado: (2022)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
por: Gorter, Thomas M., et al.
Publicado: (2023)

Association of epicardial adipose tissue with different stages of coronary artery disease: A cross-sectional UK Biobank cardiovascular magnetic resonance imaging substudy
por: van Meijeren, Anne Ruth, et al.
Publicado: (2022)

Preoperative cardiac screening using NT-proBNP in obese patients 50 years and older undergoing bariatric surgery: a study of 310 consecutive patients()
por: van Veldhuisen, Sophie L., et al.
Publicado: (2021)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
por: Yurista, Salva R., et al.
Publicado: (2020)

Pulmonary regurgitant volume is superior to fraction using background-corrected phase contrast MRI in determining the severity of regurgitation in repaired tetralogy of Fallot
por: Gorter, Thomas M., et al.
Publicado: (2015)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Pre-screening to guide coronary artery calcium scoring for early identification of high-risk individuals in the general population
por: Ties, Daan, et al.
Publicado: (2022)

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
por: Screever, Elles M., et al.
Publicado: (2023)

Improved Cardiac MRI Volume Measurements in Patients with Tetralogy of Fallot by Independent End-Systolic and End-Diastolic Phase Selection
por: Freling, Hendrik G., et al.
Publicado: (2013)

Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?
por: Ties, Daan, et al.
Publicado: (2022)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction
por: Barandiarán Aizpurua, Arantxa, et al.
Publicado: (2021)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Heart failure with preserved, mid‐range, and reduced ejection fraction across health care settings: an observational study
por: de Boer, Annemarijn R., et al.
Publicado: (2021)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence
por: Koufou, Eleni-Evangelia, et al.
Publicado: (2021)

Reduced right ventricular function on cardiovascular magnetic resonance imaging is associated with uteroplacental impairment in tetralogy of Fallot
por: Siegmund, Anne S., et al.
Publicado: (2020)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Weerts, Jerremy, et al.
Publicado: (2022)

Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fraction
por: Luo, Hongxing, et al.
Publicado: (2022)

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
por: Kloosterman, Mariëlle, et al.
Publicado: (2019)

Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction
por: Matusik, Patrycja S., et al.
Publicado: (2021)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Hypertensive crisis-induced electrocardiographic changes: a case series
por: Farha, Khalid Abou, et al.
Publicado: (2009)

Association of left ventricular strain–volume loop characteristics with adverse events in patients with heart failure with preserved ejection fraction
por: Kerstens, Thijs P, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8rgmucff0h845f9bvq948foo2f